Former Portfolio Companies

Genomic Health is focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, they launched their first test under the brand name Oncotype DX® for early stage breast cancer.

IPO in 2005 (TK: GHDX) Redwood City, CA visit www.genomichealth.com